Company news

NanoViricides, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan

May 22, 2025

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu

May 16, 2025

NanoViricides: Fiscal Q3 Earnings Snapshot

May 15, 2025

Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution

May 14, 2025

Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo

May 8, 2025

NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC

May 5, 2025

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It

April 29, 2025

← Newer news releases

Decks

The 5 newest of 9 decks. Every deck is listed under its year.